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Infection with the b-herpesvirus human cytomegalo-
virus (HCMV) is lifelong, causing limited disease in
healthy adults, but life threatening in immunocom-
promised individuals. The viral kinase pUL97, a
functional ortholog of cellular cyclin-dependent
kinases (CDKs), is critical for HCMV replication and
a target for antiviral drug development. Upon kinase
inhibition, drug-resistant strains emerge with muta-
tions in UL27, an HCMV gene of unknown function.
Using a proteomics approach, we discovered that
pUL27 is necessary and sufficient to degrade
Tip60, a host acetyltransferase and interacting
partner of HIV Tat. Consistent with this, the expres-
sion of Tat restored antiviral inhibition of an other-
wise resistant HCMV strain. The functional conse-
quence of Tip60 degradation was the induction of
the CDK inhibitor p21Waf1/Cip1 and cell-cycle arrest,
representing changes necessary for the antiviral
effects of pUL97 inhibition. Consequently, either
increasing p21Waf1/Cip1 expression or decreasing
Tip60 levels improved the antiviral activity of the
HCMV kinase inhibitor maribavir.
INTRODUCTION
A majority of the world population is infected with human cyto-
megalovirus (HCMV) (for review, see Mocarski et al., 2007).
HCMV is a member of the b-herpesvirus family, and, like all
herpesviruses, infection is lifelong. HCMV causes limited
disease in healthy adults, but long-term persistent infection is
linked to atherosclerosis. However, infection in immunocompro-
mised people, including AIDS patients, is life threatening and
requires treatment with anti-CMV pharmaceutical drugs. The
current frontline anti-CMV pharmaceutical drugs inhibit genome
replication, and these include ganciclovir, cidofovir, and foscar-
net. However, the use of these compounds is limited due toCell Hostconcerns regarding toxicity, poor oral bioavailability, modest
efficacy, and development of resistant viral strains.
The HCMV protein kinase, pUL97, is required at multiple steps
during viral replication and has been a candidate enzymatic
target for the development of antiviral compounds. The kinase
is a functional ortholog to cellular cyclin-dependent kinases
(CDKs) (Hamirally et al., 2009; Hume et al., 2008), phosphory-
lating and altering the activity of several key cellular proteins.
Along with pUL97, expression of additional viral proteins causes
infected cells to accumulate in a unique pseudo-G1 state, which
is necessary for efficient replication (for review, see Sanchez and
Spector, 2008). HCMV pUL97 is also necessary for virion
assembly, functioning to disrupt the nuclear lamina upon particle
egress (Hamirally et al., 2009). A specific inhibitor of pUL97
kinase activity is the pharmaceutical drug maribavir (MBV) (for
review, see Prichard, 2009). However, as with other antiviral
agents, propagating HCMV in the presence of MBV selects for
mutants resistant to the compound. MBV-selected mutations
occur in the UL97 gene as well as in a gene of unknown function,
UL27. The selection of mutations in UL27 is directly related to
pUL97, since replication of a pUL97-deficient virus in the
absence of MBV also promotes mutations within the UL27
gene (Chou, 2009).
Our studies have identified Tip60 (Tat interactive protein) ace-
tyltransferase protein as a target of pUL27 during infection. Tip60
is an essential protein with homozygous disruption causing early
embryonic lethality (Hu et al., 2009). Tip60 is a participant in the
DNA damage response, regulating cell-cycle progression and
apoptosis by acetylating histones and nonhistone proteins,
including p53, ATM, and c-MYC (for review, see Squatrito
et al., 2006). Tip60-regulated responses are context dependent
and often involve interactions with the chromatin-remodeling
protein p400 (Mattera et al., 2009; Park et al., 2010). Under
unstressed conditions, Tip60 localizes to E2F- and c-MYC-
regulated promoters, inducing transcription and S phase entry
(DeRan et al., 2008; Frank et al., 2003; Taubert et al., 2004).
Tip60 also negatively regulates p73-mediated p21Waf1/Cip1
expression (Kim et al., 2008), and disruption of Tip60 in prostate
cancer cells results in a G1 arrest (Shiota et al., 2010).
Conversely, upon genotoxic stress, Tip60 is required for p53-
regulated cell-cycle arrest and apoptosis.& Microbe 9, 103–114, February 17, 2011 ª2011 Elsevier Inc. 103
Figure 1. UL27 Mutant Viruses Display
Enhanced Viral Replication in the Presence
of Maribavir
(A) Recombinant HCMV variants were constructed
by BAC recombineering. ADsub27 contains a stop
codon, TAA, in place of the UL27 starting ATG,
while ADdel27 contains the bacterial galK gene
in place of a portion of UL27.
(B) Fibroblasts were infected at 0.25 pfu/cell with
wild-type (WT), ADsub27 (sub27), or ADdel27
(del27) viruses. Maribavir (MBV) or DMSO was
added 2 hpi. Viral titers were determined from
culture supernatants obtained at 96 hpi. Data
represent two replicate experiments and are pre-
sented as the percentage ofMBV-mediated inhibi-
tion to DMSO control (MBV). Values are given as
the mean ± SEM (*p < 0.01, **p < 0.001).
(C) Fibroblasts were infected as described above,
and titers were determined from culture superna-
tants collected at several time points. HCMV
genome replication was quantified by qPCR.
The data were normalized to cellular DNA. Data
represent two replicates and are presented as
the mean ± SEM (**p < 0.001).
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HCMV pUL27 and Tip60 in Antiviral SusceptibilityUnderstanding howHCMV controls the cellular environment is
of utmost importance for the development of effective long-term
treatments against infection. We have used a focused proteo-
mics approach to assist in identifying the function of the HCMV
pUL27 and how its activity relates to the efficacy of a kinase
inhibitor as an antiviral agent. We demonstrate that pUL27
expression causes degradation of the Tip60 acetyltransferase,
resulting in a cell-cycle arrest and sensitivity to the antiviral agent
MBV.
RESULTS
HCMV UL27 Is Necessary for the Antiviral Activity
of Maribavir
Past studies demonstrated a requirement for the UL27 gene in
the antiviral effects of the viral kinase inhibitor MBV (Chou
et al., 2004; Komazin et al., 2003). To investigate the contribution
of UL27 to antiviral resistance, we disrupted the UL27 ORF in
HCMV strain AD169, either by replacing a portion of UL27 with
a nonspecific sequence in ADdel27 or by replacing the starting
codon of the UL27 ORF with a stop codon in a second mutant
virus, ADsub27 (Figure 1A). These viruses replicated with wild-
type growth kinetics (Figure S1), and western blot analysis
demonstrated expression of neighboring pUL26 and pUL29/28
proteins (Figure S1). To determine if UL27-deficient viruses
were inhibited by MBV, we infected fibroblasts that were
synchronized in G0/G1 by contact inhibition with ADwt,
ADsub27, or ADdel27, using media containing either 40 mM of
MBV or equivalent volume of DMSO alone. We observed a
20-fold reduction of ADwt virus produced at 96 hpi, as compared
to a 3-fold reduction for both UL27-deficient viruses (Figure 1B).
These differences were maintained following several rounds of104 Cell Host & Microbe 9, 103–114, February 17, 2011 ª2011 ElsevADwt and ADsub27 replication (Figure 1C). Our data support
the conclusion that MBV-mediated inhibition of the viral kinase
disrupts HCMV replication through both UL27-dependent and
UL27-independent mechanisms.
To determine where in the replication cycle UL27 alters the
effect of MBV, we evaluated HCMV genome replication.
Contact-inhibited fibroblasts were infected with either ADwt or
ADsub27 using media containing either MBV or DMSO. We
quantified changes in genome replication by qPCR, using total
DNA isolated from infected cells. In the presence of MBV, we
detected a 5-fold reduction in ADwt genomes at 96 hpi, as
compared to a 1.3-fold decrease for ADsub27 (Figure 1C). These
data suggest that UL27 is partially antagonizing UL97, at or
before DNA replication.
HCMV pUL27 Is Expressed within the Nucleus
during Infection
It remains to be determined if a protein is expressed from the
UL27 ORF during infection. The gene resides within a transcrip-
tion unit containing the UL29 to UL26 genes (Figure 2A). To
define transcripts containing the UL27 ORF, we performed 50
rapid amplification of cDNA ends on total RNA isolated from
infected cells. We identified a putative transcriptional start site
at nt 34699, which is 42 nt upstream of the predicted UL27 start-
ing ATG (Figure 2A). Using qRT-PCR, expression of UL27 RNA
was detected as early as 4 hpi, occurring just after the onset of
immediate-early UL123 RNA expression (Figure 2B). RNA
expression kinetics were similar to that of the early-late UL44
and UL97 genes (Figure 2B).
In the absence of an antibody to pUL27, we constructed a
recombinant virus, ADin27F, which contains three repeats of
the FLAG epitope tag on the amino terminus (Figure 2C).ier Inc.
Figure 2. HCMV pUL27 Is Expressed Very Early during Infection within the Nucleus
(A) The UL27 transcriptional start site was mapped using 50 RACE analysis to nt 34,699 of strain AD169 (accession X17403). Previously mapped transcripts from
the locus and putative cis elements are indicated.
(B) Fibroblasts were infected at 0.25 pfu/cell using WT virus, and expression of RNAs was quantified by qRT-PCR. Data represent two replicate experiments and
are presented as the mean ± SEM.
(C) Recombinant virus expressing a 33 FLAG tag on the amino terminus of pUL27 (ADin27F).
(D) Fibroblasts were infectedwith wild-type (WT) or ADin27F (in27F) virus. Viral titers were determined from culture supernatants. MBV resistancewas determined
by treating cells with 40 mM of MBV or DMSO control and normalizing titers to DMSO control (MBV). Data represent two replicates and are presented as the
mean ± SEM.
(E) Whole-cell lysates were prepared from fibroblasts infected at 3 pfu/cell with in27F virus. Expression was determined by western blot using the indicated anti-
bodies.
(F) Cells were infected at 0.5 pfu/cell using in27F virus and processed for immunofluorescence analysis using an anti-FLAG antibody (green), lectin (red), and
DAPI (blue).
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HCMV pUL27 and Tip60 in Antiviral SusceptibilityADin27F replicated with wild-type kinetics (Figure 2D). To assess
whether pUL27 remained functional, we completed a growth
curve in the presence of MBV treatment. Unlike the UL27-
deficient virus, MBV was as effective in inhibiting ADin27F
as the parental wild-type strain under these conditions (Fig-
ure 2D). We conclude that the addition of the FLAG epitopeCell Hostdoes not alter the functioning of pUL27 as it relates to the effi-
cacy of MBV.
To demonstrate expression of pUL27, we infected primary
fibroblasts and completed western blot analysis, using an anti-
body to the FLAG epitope. A unique band was observed, at
72 kDa in size, which corresponds to the predicted size of& Microbe 9, 103–114, February 17, 2011 ª2011 Elsevier Inc. 105
Figure 3. pUL27 Disrupts the Host Cell Cycle
(A) U2OS cells were transfected with 10 mg of pCGN-UL27 and/or pCGN-UL82 (pp71) expression plasmids and cultured in serum for 40 hr before analysis. Cells
were treated with nocodazole for 16 hr, released, and analyzed at the indicated times, using propidium iodide and HA-specific antibody staining. Flow cytometry
was used to quantify staining.
(B) The data represent statistical significance from four replicate experiments and a representative histogram. Values are given as the mean ± SEM (*p < 0.05,
**p < 0.01).
(C) Fibroblasts stably expressing pUL27myc were evaluated by immunofluorescence, using an antibody to myc (green) and DAPI (blue). Doubling times for fibro-
blasts (HF) and those expressing either empty vector control (cont) or pUL27myc (UL27) were determined by flow cytometry every 24 hr for 5 days. Data represent
three replicates and are given as the mean ± SEM. Western blot analysis was completed on control and UL27 cells, using the indicated antibodies.
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HCMV pUL27 and Tip60 in Antiviral Susceptibilitythe pUL27 fused with the FLAG epitope (Figure 2E). pUL27
expression was detectable beginning between 4 and 6 hpi (Fig-
ure 2E). We also evaluated changes in pUL27 expression relative
to other HCMV proteins. pUL27 expression occurred 2 hr after
the appearance of the immediate early protein, pUL123 (Fig-
ure 2E). The onset of expression of both pUL27 and pUL123
occurred prior to the late proteins pUL26 and pUL99 (Figure 2E).
We observed the majority of pUL27 within the nucleus (Fig-
ure 2F), which is consistent with past studies transiently express-
ing the UL27 ORF (Chou et al., 2004). We conclude that the
pUL27 protein is expressed very early during infection and is
predominantly localized within the nucleus.
pUL27 Inhibited the Cell Cycle and Increased
Expression of p21Waf1/CiP1
Numerous HCMV proteins function by regulating the cellular
environment, which indirectly affects viral replication kinetics.
Because the target of MBV is the pUL97 viral kinase, which influ-
ences cell cycling (Hume et al., 2008; Kamil et al., 2009), we were
interested in determining the impact of pUL27 expression on the
cell cycle. We completed these studies using a transient trans-106 Cell Host & Microbe 9, 103–114, February 17, 2011 ª2011 Elsevfection system due to the complexity of cell-cycle regulation
during infection (for review, see Sanchez and Spector, 2008).
We transfected U2OS cells with a pUL27 expression vector con-
taining the hemagglutinin (HA) epitope tag. As a control, we
transfected an HA-tagged HCMV pp71 expression vector. At
24 hr posttransfection, we synchronized cells at the G2/M phase
by adding nocodazole for 16 hr (Figure 3A). To quantify the
impact of pUL27 expression, cells were released from nocoda-
zole arrest and DNA content was evaluated at 0 and 12 hr post-
release. Cells expressing pUL27 or pp71 were identified by flow
cytometry using the nonexpressing untransfected (untrx) cells
within the population as control. Based upon DNA content, we
quantified the relative number of cells in G0/G1, S, or G2/M
phases of the cell cycle.
Nocodazole treatment resulted in R70% of untrx and pp71-
expressing cells accumulating in G2/M (Figure 3B). However,
only 40% of the cells expressing pUL27 were detected in
G2/M, while the majority of these cells accumulated within the
G0/G1 phase (Figure 3B). After 12 hr, untrx and pp71-expressing
cells resumed their progression through the cell cycle with only
30% of cells in G2/M (Figure 3B). However, we observed noier Inc.
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HCMV pUL27 and Tip60 in Antiviral Susceptibilitychange for cells expressing pUL27 (Figure 3B). We conclude that
expression of pUL27 inhibits the cell cycle.
We next determined whether the pUL27-mediated arrest
could be overcome by expression of the cell-cycle-promoting
protein pp71. HCMV pp71 mediates proteasome-dependent
degradation of pRB (Kalejta et al., 2003). Upon coexpression
of pUL27 and pp71, we detected a modest increase in cells
synchronized at G2/M and a decrease at G0/G1, compared to
pUL27 alone (Figure 3B). Under these conditions, we determined
by immunofluorescence that coexpression by transfection
occurred in 87% ± 4% of the cells (data not shown). At 12 hr
after nocodazole release, the cell-cycle profile of cotransfected
cells resembled the untrx control and pp71-expressing cells
(Figure 3B). These data suggest that expression of pp71 can
partially overcome the inhibitory effects of pUL27 on cell-cycle
progression.
We also determined the impact of pUL27 expression on
primary fibroblasts. For these studies, we transduced fibroblasts
and selected for expression of pUL27 containing a myc epitope
tag. Expression of pUL27 was observed within the nucleus of the
majority of cells in this population (Figure 3C). Under these
conditions, we observed a significant delay in the growth of
pUL27-expressing fibroblasts compared to cells containing
empty vector. To quantify this difference, the cell-doubling times
were determined for untreated primary fibroblasts (HF), vector
control cells (cont), and pUL27-expressing cells (UL27). HF
and cont exhibited a 25–30 hr doubling time, while UL27 took
60 hr (Figure 3C). We conclude that pUL27 expression causes
a substantial delay in the cell cycle of primary human fibroblasts.
Since disruption of pRB by pp71 can overcome the pUL27-
mediated arrest, we investigated if expression of an upstream
regulator of pRB, the CDK inhibitor p21Waf1/Cip1, was altered.
Upon expression of pUL27, we observed a substantial increase
in the steady-state levels of p21Waf1/Cip1, usingwestern blot anal-
ysis (Figure 3C). No change was observed in the levels of
a second CDK inhibitor, p16INKa. Our data indicate that pUL27
expression causes a cell-cycle arrest, and this response is asso-
ciated with increased expression of p21Waf1/Cip1.
pUL27 Interacts with Components of the Tip60 Complex
and Proteasome during Infection
In order to identify the molecular mechanism used by pUL27 to
influence the cell cycle, we examined pUL27-interacting proteins
during infection. For these experiments, we infected primary
fibroblasts at a multiplicity of 3 pfu per cell with ADin27F virus
(Figure 2C). At 24 hpi, pUL27 and the associated proteins were
isolated from cell extracts by immunoaffinity purification (Moor-
man et al., 2008) using an antibody to the FLAG epitope. Isolated
proteins were resolved by electrophoresis and identified by
mass spectrometry. To identify nonspecific interactions, we
repeated the method using the parental virus, which does not
express a FLAG epitope. These proteins were removed from
the list of proteins observed during ADin27F infection. The
studies were completed in triplicate, and putative pUL27-inter-
acting proteins are presented in Table 1 and a complete list in
Table S1.
Our analysis identified putative interactions with components
of the Tip60 acetyltransferase complex, the ubiquitin-dependent
and -independent proteasomes, and STAT3 (Table 1). CoreCell Hostcomponents of the Tip60 complex detected included TRRAP,
EP400, TIP48, TIP49, and ACL6A (Cai et al., 2005; Doyon
et al., 2004). An additional Tip60-binding protein observed was
STAT3 (Xiao et al., 2003). Our studies identified numerous
protein components of the cellular proteasomes (for review,
see Sorokin et al., 2009). This includes the ubiquitin-independent
11S regulator (PSME3), ubiquitin-dependent 19S regulator
(PSMC4, PSMD14, PSMD2, PSMC6, PSMD3), and 20S catalytic
core (PSMA3, PSMB6, PSMB4). Our experiments identified
proteins associated with pUL27 based on a global false
discovery rate of 5% and, therefore, further study is needed to
confirm the identified proteins as interacting partners.
pUL27 Is Necessary and Sufficient for
Proteasome-Dependent Degradation of Tip60
Tip60 acetyltransferase is a component of the Tip60 complex
and regulates both apoptosis and the cell cycle. Although
several protein components of the Tip60 complex were detected
in our experiments, Tip60 itself was not observed.We next deter-
mined whether Tip60 can interact with pUL27. For these studies,
we infected fibroblasts with ADin27F virus and immunoprecipi-
tated proteins using an antibody against Tip60. A protein at the
correct molecular weight of pUL27 was detected by western
blot analysis, using an antibody to FLAG (Figure 4A). We failed
to observe pUL27 in the uninfected sample and by using the iso-
type control antibody (Figure 4A). To validate an interaction with
a second component of the complex, we repeated the experi-
ments using an antibody against TRRAP. Western blot analysis
detected pUL27 in the infected sample, but not in the uninfected
or isotype control samples (Figure 4A). For both Tip60 and
TRRAP, only a fraction of the total amount of pUL27 expressed
interacted. We conclude that pUL27 interacts with components
of the Tip60 complex, including the Tip60 acetyltransferase itself
at 24 hpi.
Several proteins have been identified as regulators of Tip60
activity during infection by other viruses. Expression of HIV Tat
(Col et al., 2005) and HPV E6 (Jha et al., 2010) mediate protea-
some-dependent degradation of Tip60 while HTLV-1 p30II stabi-
lizes Tip60 (Awasthi et al., 2005). To determine if HCMV infection
alters Tip60 protein levels, we completed western blot analysis
during infection. A decrease in Tip60 levels was observed early
during infection, with a 3-fold reduction in western blot signal
occurring by 6 hpi, compared to mock (Figure 4B). However,
by 72 hpi, this difference was resolved (Figure 4B). We next
investigated if pUL27 contributes to the decrease by infecting
with ADsub27 or ADdel27. Infection with these pUL27-deficient
viruses failed to alter Tip60 levels (Figure 4B). Our data indicate
that pUL27 contributes to the transient decrease in Tip60 protein
during infection. To determine the role of the proteasome, we
repeated the experiments in the presence of the proteasome
inhibitor MG132 at 8 hpi. The addition of MG132 resulted in
increased Tip60 levels, compared to those observed in the unin-
fected treated and untreated control samples (Figure 4C). Tip60
RNA expression was not altered under these conditions (Fig-
ure 4C). Taken together, these results lead us to conclude that
pUL27 is necessary for the proteasome-dependent degradation
of the Tip60 acetyltransferase during infection.
To determine whether additional HCMV proteins are required
for the interaction between pUL27 and Tip60, we cotransfected& Microbe 9, 103–114, February 17, 2011 ª2011 Elsevier Inc. 107
Table 1. Putative HCMV pUL27-Interacting Proteins during Viral Infection at 24 Hr Postinfection
Source Symbol Accession Official Name (Alternative Names) Complexb
Peptide
Count
Scan
Count
Percent
Coverage
Viral UL27 P16763 23 263 39
Cellulara TRRAP Q9Y4A5 transformation/transcription domain-associated
protein (Tra1; TR-AP; PAF400; STAF40)
Tip60 37 45 14
PSME3 P61289 proteasome (prosome, macropain) activator
subunit 3 (Ki; PA28G; REG-g; PA28-g)
11S 16 195 64
UBR5 O95071 ubiquitin protein ligase E3 component n-recognin 5
(DD5; EDD; HYD; EDD1)
Ubiquitin
ligase
10 18 7
EP400 Q96L91 E1A-binding protein p400 (p400; CAGH32; TNRC12) Tip60 9 10 4
ACLY P53396 ATP-citrate synthase (ACL; ATPCL; CLATP) – 7 19 8
RUVBL2 Q9Y230 RuvB-like 2 (RVB2; TIH2; ECP51; TIP48) Tip60 7 14 24
RAN Q9CWI7 RAN, member RAS oncogene family – 6 17 34
HNRNPH3 P31942 heterogeneous nuclear ribonucleoprotein H3
(2H9; HNRPH3)
– 6 34 23
CBR1 P16152 carbonyl reductase (CBR; hCBR1; SDR21C1) – 6 12 36
PSMC4 P43686 proteasome (prosome, macropain) 26S subunit,
ATPase, 4 (S6; TBP7)
19S 5 10 14
FKB10 Q96AY3 FK506 binding protein 10, 65 kDa (OI6; FKBP65;
PPIASE; hFKBP65)
– 5 12 11
PSMA3 P25788 proteasome (prosome, macropain) subunit,
alpha type, 3 (HC8; PSC3)
20S 5 10 22
RUVBL1 Q9Y265 RuvB-like 1 (RVB1; TIH1; ECP54; TIP49) Tip60 5 11 16
NUDT21 O43809 nudix (nucleoside diphosphate linked
moiety X)-type motif 21 (CPSF5; CFIM25)
– 5 13 27
TMEM43 Q9BTV4 transmembrane protein 43 (LUMA; ARVC5; ARVD5) – 5 10 22
RAB1A P62820 RAB1A, member RAS oncogene family (RAB1; YPT1) – 5 26 26
PDIA4 P13667 protein disulfide isomerase family A, member 4
(ERP70; ERP72; ERp-72)
– 5 9 11
Cellularc PSMD14 O00487 proteasome (prosome, macropain) 26S subunit,
non-ATPase, 14 (RPN11; PAD1; POH1)
19S 4 8 25
PSMB6 P28072 proteasome (prosome, macropain) subunit,
beta type, 6 (Y; LMPY; DELTA)
20S 3 4 13
ACL6A O96019 actin-like protein 6A (Arp4; ACTL6; BAF53A; INO80K) Tip60 3 6 7
DDB1 Q16531 damage-specific DNA-binding protein 1,
127 kDa (XPE; DDBA; XAP1; XPCE)
Ubiquitin
ligase
3 10 5
WDR26 Q9H7D7 WD repeat protein 26 (CDW2; MIP2) Ubiquitin
ligase
3 3 7
PSMB4 P28070 proteasome (prosome, macropain) subunit,
beta type, 4 (HN3; HsN3; PROS26; PROS-26)
20S 3 7 22
PSMD2 Q13200 proteasome (prosome, macropain) 26S subunit,
non-ATPase, 2 (RPN1; S2; P97; TRAP2)
19S 3 8 5
PSMC6 P62333 proteasome (prosome, macropain) 26S subunit,
ATPase, 6 (RPT4; P44; p42; SUG2)
19S 3 6 11
PSMD3 O43242 proteasome (prosome, macropain) 26S subunit,
non-ATPase, 3 (RPN3; S3; P58; TSTA2)
19S 3 8 7
STAT3 P40763 signal transducer and activator of transcription 3
(acute-phase response factor) (APRF)
Tip60 2 3 4
a Peptide countR5.
b Interactions with known complexes.
c Component of indicated complexes with peptide count <5.
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HCMV pUL27 and Tip60 in Antiviral SusceptibilityTip60-FLAG and pUL27 expression vectors into U2OS cells.
We immunoprecipitated Tip60 using an antibody to the FLAG
epitope and completed western blot analysis against pUL27HA.108 Cell Host & Microbe 9, 103–114, February 17, 2011 ª2011 ElsevAn interaction was observed between transiently expressed
Tip60 and HCMV pUL27 (Figure 4D), indicating that no additional
viral proteins are required. We also confirmed an interaction ofier Inc.
Figure 4. pUL27-Induced Degradation of Tip60 Acetyltransferase
(A) Fibroblasts were infected at 3 pfu/cell using in27F virus. Immunoprecipitations (IP) were completed at 24 hpi, using antibodies to Tip60, TRRAP, or isotype-
control IgG and western blot (WB) using the indicated antibodies. Lysate controls used 2% of the total lysate used for IP.
(B) Cells were infected with WT, sub27, or del27 viruses. Western blot was completed using the indicated antibodies. Tip60 levels were quantified relative to
GAPDH and mock (M) by densitometry from four replicate experiments using WT or sub27 viruses. Values are given as the mean ± SEM (*p < 0.05).
(C) Fibroblasts were infected with in27F, and 30 mMMG132 or DMSO was added at 1 hpi. Western blot was completed at 8 hpi using the indicated antibodies.
RNA levels were determined by qRT-PCR and primers specific to the Tip60 cDNA from three replicates. Values are normalized to GAPDH RNA and given as the
mean ± SEM.
(D) U2OS cells were transfected with vector or pCGN-UL27 and pCMV-7.1-Tip60 expression plasmids. Immunoprecipitations were completed after 48 hr using
an antibody to Tip60-FLAG, followed by western blot using the indicated antibodies. U2OS cells were transfected with vector or pCGN-UL27, and immunopre-
cipitations were completed after 48 hr using an antibody to p400, followed by western blot using the indicated antibodies. Lysate controls used 2% of the total
lysate used for IP.
(E) U2OS cells were transfected with vector, pCMV-Tat, or 0.5, 1.0, or 2.0 mg of pCGN-UL27. Western blot was completed using indicated antibodies. Tip60 RNA
levels were determined by qRT-PCR from three replicates. Values are given as the mean ± SEM.
(F) U2OS cells were cotransfected with vector, pCMV-Tat, or pCGN-UL27 and increasing amounts of pCMV-7.1-Tip60. Total RNA was used to quantify p21
expression by qRT-PCR. Data represent two replicates, and values are given as the mean ± SEM.
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HCMV pUL27 and Tip60 in Antiviral SusceptibilitypUL27 with an additional component of the Tip60 complex,
p400 (Figure 4D), which was identified by mass spectrometry
(Table 1). We next examined if pUL27 was sufficient to mediate
the decrease in endogenous Tip60 levels. For these experi-
ments, increasing amounts of the pUL27 expression vector
were transfected into U2OS cells. Transfection of the empty
expression plasmid served as a negative control, and an HIV
Tat expression vector was a positive control. Upon the expres-
sion of pUL27, we observed a decrease in endogenous levelsCell Hostof Tip60 protein (Figure 4E). Tip60 RNA expression was not
altered under these conditions (Figure 4E). We also observed
an increase in protein expression of p21Waf1/Cip1 (Figure 4E).
Another cell-cycle regulator, cyclin D1, was unaffected (Fig-
ure 4E). To determine if the induction of p21Waf1/Cip1 was at the
level of transcription, we cotransfected either empty vector,
Tat, or pUL27 expression vectors with increasing amounts of
Tip60 and quantified changes in RNA. Expression of pUL27
resulted in a 5-fold induction in p21Waf1/Cip1 RNA expression,& Microbe 9, 103–114, February 17, 2011 ª2011 Elsevier Inc. 109
Figure 5. PSME3 Regulates p21Waf1/Cip1 but Not pUL27-Induced
Tip60 Degradation
(A) Fibroblasts were infected at 3 pfu/cell using in27F virus. Immunoprecipita-
tions (IP) completed at 24 hpi using antibodies to PSME3 or isotype-control
IgG were followed by western blot using the indicated antibodies. Lysate
controls used 2% of the total lysate used for IP.
(B) Short hairpin RNA (shRNA) sequences to scrambled control (shScram) or
PSME3 (shPSME3-1, -2, -3) were expressed in fibroblasts. Protein levels
were determined by western blot. Cell-doubling times for shScram (scrm)
and shPSME3-3 (sh3-3) were determined by flow cytometry every 24 hr for
5 days. Data represent two replicate experiments, and values are given as
the mean ± SEM.
(C) Fibroblasts expressing shScram (scrm) or shPSME3-3 (sh3-3) were in-
fected at 3 pfu/cell using in27F virus. A western blot was completed using
the indicated antibodies.
(D) Fibroblasts expressing shRNA sequences were infected at 0.25 pfu/cell
with either WT or sub27 viruses. Viral genomes were quantified by qPCR,
normalized to cellular DNA, and presented relative to scrm at 96 hpi. Data
represent two replicates, and values are given as the mean ± SEM (*p < 0.05).
(E) Cells including untransduced fibroblasts (HF) were infected at 0.25 pfu/cell
using WT virus and treated with 40 mM MBV or DMSO. Viral genomes were
quantified at 96 hpi by qPCR, normalized to cellular DNA, and presented rela-
tive to DMSO control for each condition. Viral titers were determined from
culture supernatants obtained at 96 hpi. Data represent two replicates, and
values are given as the mean ± SEM (*p < 0.05).
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ure 4F). From these studies, we conclude that expression of
pUL27 is sufficient to mediate a decrease in endogenous Tip60
acetyltransferase protein levels and an increase in p21Waf1/Cip1
RNA and protein expression.
Tip60 Degradation Occurs Independently
of the Proteasome Regulator PSME3
We identified PSME3, also known as REG-g or PA28, as a
putative pUL27-interacting protein (Table 1). PSME3 is the ubiq-
uitin-independent 20S proteasome activator protein. To confirm
the interaction, we performed the reciprocal experiment, as
compared to the initial MS analysis, by infecting fibroblasts using
an antibody against PSME3. A protein corresponding to the
molecular weight of pUL27F was detected by western blot anal-
ysis, but not in the uninfected sample or using an isotype control
antibody (Figure 5A). We conclude that pUL27 interacts with
PSME3 during infection.
To determine if Tip60 degradation is dependent on PSME3, we
disrupted PSME3 by expressing specific short hairpin RNA
(shRNA) sequences within primary fibroblasts. We analyzed
changes in PSME3 protein expression by western blot and
observed the greatest reduction in PSME3 using the sequence
shPSME3-3, as compared to shRNA control cells (Figure 5B).
Disruption of PSME3 expression influences the cell cycle at the
G1 phase (Chen et al., 2007; Li et al., 2007). To determine if the
observed decrease could alter PSME3 activity, we quantified
the cell-doubling times between shRNA-expressing cells.
Disruption of PSME3 resulted in a dramatic increase in doubling
time to 75 hr, as compared to 25 hr for the control cells (Fig-
ure 5B). We next investigated if pUL27-mediated degradation
of Tip60 was dependent on PSME3 expression. Cells were
infected using ADin27F, and western blot analysis was
completed. Under these conditions, we observed that disruption
of PSME3 expression did influence Tip60 levels (Figure 5C), but
Tip60 degradation still occurred during infection. We conclude
that pUL27-induced degradation of Tip60 is independent of
PSME3.
Previous studies have demonstrated that disruption of PSME3
results in elevated p21Waf1/Cip1 protein levels (Chen et al., 2007).
As expected, we observed a dramatic increase in p21Waf1/Cip1 in
cells expressing reduced levels of PSME3, and this pattern was
maintained during infection up to 24 hpi (Figure 5C). To investi-
gate if HCMV requires PSME3 for efficient replication, we
infected primary fibroblasts using wild-type and ADsub27
viruses and quantified viral genome replication at 96 hpi.
Using qPCR, we observed that disruption of PSME3 resulted
in a 4-fold increase in wild-type replication while having no
significant impact on UL27-deficient replication (Figure 5D). To
determine if PSME3 influences the efficacy of MBV, shRNA-ex-
pressing cells were infected and treated with either MBV or
DMSO control. We observed that MBV was significantly more
effective in inhibiting replication in cells with reduced PSME3
levels (Figure 5E). HCMV genome replication was inhibited
by 50-fold, as compared to 3-fold observed in control cells,
which was accompanied by decreased virus yield (Figure 5E).
We conclude that disruption of PSME3 enhanced the replication
of wild-type virus yet improved the efficacy of the antiviral
compound, MBV.110 Cell Host & Microbe 9, 103–114, February 17, 2011 ª2011 Elsevier Inc.
Figure 6. Reduced Tip60 Expression Restores Maribavir Activity to a UL27-Deficient Virus
(A) Short hairpin RNA sequences to scrambled control (shScram) and Tip60 (shTip60-2, -3) were expressed in fibroblasts. Protein expression was determined by
western blot and quantified by densitometry. Fibroblasts were infected at 0.25 pfu/cell using WT or sub27 virus. Cells were treated with 40 mM MBV or DMSO.
Viral genomeswere quantified at 96 hpi by qPCR, normalized to cellular DNA, and presented relative to DMSO control. Data represent two replicate experiments,
and values are given as the mean ± SEM (*p < 0.05).
(B) Fibroblasts were transfected with vector or an HIV Tat expression vector and infected at 0.25 pfu/cell usingWT or sub27 virus. Cells were treated with 40 mM
MBV or DMSO. Viral genomes were quantified at 96 hpi as described above. Data represent two replicates, and values are given as the mean ± SEM (*p < 0.05).
(C) Experiments were repeated using 200 ng/ml of purified Tat or PBS added to the culture media of untransfected cells. Viral genomes were quantified by
qPCR as described above. Viral titers were determined from culture supernatants obtained at 96 hpi. Data represent two replicates, and values are given as
the mean ± SEM (*p < 0.05).
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Activity of MBV to a pUL27-Deficient Virus
Our studies have demonstrated that pUL27 expression
promotes the degradation of Tip60 during infection (Figure 4B).
To investigate if Tip60 degradation is involved in the antiviral
activity of MBV, we disrupted Tip60 expression within fibro-
blasts, using sequence-specific shRNAs to either Tip60 or a
scrambled control. Tip60 expression was analyzed by western
blot analysis, which detected a substantial reduction in endoge-
nous Tip60 levels (Figure 6A). Because Tip60 is a known regu-
lator of p21Waf1/Cip1, we evaluated changes in p21Waf1/Cip1
expression by western blot analysis. We observed an increase
in p21Waf1/Cip1 expression upon disruption of Tip60 (Figure 6A).
These data indicate that Tip60 regulates p21Waf1/Cip1 expression
in the absence of pUL27. This amount of reduction in Tip60 levels
did not affect HCMV replication in cell culture (data not shown).
We next investigated whether disruption of Tip60 was sufficient
to restore MBV-mediated inhibition of replication for a pUL27-
deficient virus. We infected cells using either wild-type or
ADsub27 virus in the presence of MBV or DMSO and quantified
changes in genome replication. MBV inhibited ADsub27 replica-
tion in cells with reduced Tip60 protein levels as compared to the
scrambled control (Figure 6A). We conclude that reducing Tip60Cell Hostis sufficient to restore the inhibition of HCMV DNA replication by
MBV in the absence of pUL27 expression.
Previous studies demonstrated that expression of HIV Tat
causes Tip60 degradation (Col et al., 2005). To determine if Tat
is sufficient to restore MBV activity in the absence of pUL27,
we transfected fibroblasts with either an empty vector or a Tat
expression vector. Cells were infected using either wild-type
virus or ADsub27 in the presence of MBV or DMSO. Upon
expression of Tat, we observed that DNA replication of the
pUL27-deficient virus was inhibited by MBV to the same degree
observed when using wild-type virus (Figure 6B). A unique
feature of Tat is its ability to be secreted from infected cells
and taken up by neighboring cells (for review, see Li et al.,
2010). Tat protein concentrations have been observed as high
as 550 ng/ml in sera of HIV-infected individuals (Poggi et al.,
2004). Therefore, we investigated if purified Tat added to the
culture media was sufficient to restore MBV activity. We added
Tat at 200 ng/ml or PBS control to the culture media 24 hr prior
to infection and again at 48 hpi (Roy et al., 2008). Fibroblasts
were infected in the presence of MBV or DMSO, and we quanti-
fied HCMV DNA replication and virus release. We observed the
rescue of MBV-mediated inhibition of a pUL27-deficient virus
upon the addition of Tat (Figure 6C). Taking these results& Microbe 9, 103–114, February 17, 2011 ª2011 Elsevier Inc. 111
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either by shRNAs or HIV Tat, is sufficient to restore the effective-
ness of MBV to inhibit HCMV replication in the absence of
pUL27.
DISCUSSION
We have demonstrated that HCMV pUL27 interacts with compo-
nents of the cellular Tip60 acetyltransferase complex. This inter-
action resulted in proteasome-dependent degradation of the
Tip60 protein. However, HCMV-mediated degradation was inde-
pendent of the proteasome protein PSME3, which also interacts
with pUL27. During infection, pUL27-mediated decrease in
Tip60 levels was transient and overlapped with the expression
kinetics of pUL27. These data suggest that pUL27 functions
within a short time frame during infection. Regardless of the tran-
sient nature of the response, we have demonstrated that pUL27
is necessary to fully promote Tip60 degradation. The decrease in
Tip60 levels was initiated prior to the detection of pUL27 and
pUL123 expression, suggesting the contribution of a virion-deliv-
ered protein in this process. However, in the absence of infec-
tion, expression of pUL27 was sufficient to mediate Tip60
degradation.
The functional consequence of pUL27 expression is an arrest
in the cell cycle. Tip60 has previously been demonstrated to
either promote or repress cell-cycle progression in a context-
dependent manner. We have shown that the pUL27-induced
degradation of Tip60 resulted in elevated levels of p21Waf1/Cip1.
These data suggest that Tip60 is a negative regulator of
p21Waf1/Cip1 gene expression, which has been previously
demonstrated by interactions of Tip60 with both p73 and
MDM2 (Kim et al., 2008). Alternatively, expression of pUL27
may alter the p400-containing Tip60 complex (Ge´vry et al.,
2007; Mattera et al., 2009; Park et al., 2010). Regardless,
pUL27 increased p21Waf1/Cip1 expression with an accompanying
increase in the cell-doubling time. This increase in p21Waf1/Cip1
was correlated with the decrease in Tip60 protein levels. During
infection, inhibition of CDKs and increased p21Waf1/Cip1 expres-
sion control the onset of IE gene expression (Zydek et al.,
2010). Our studies suggest that pUL27 participates in regulating
p21Waf1/Cip1 expression at very early times during infection via its
interaction with Tip60. After 24 hpi, p21Waf1/Cip1 protein levels
decrease by both proteasome- and calpain-dependent mecha-
nisms (Chen et al., 2001).
How does the pUL27-induced cell-cycle arrest contribute to
the efficacy of MBV?We hypothesize that, in the absence of viral
kinase activity, pUL27 expression prevents viral replication by
arresting infected cells prior to their reaching the necessary
pseudo-G1 phase. pUL97 phosphorylates several substrates
including pRB (Hume et al., 2008; Kamil et al., 2009; Prichard
et al., 2008). Hyperphosphorylation of pRB promotes cell-cycle
progression through G1. Because pUL27 is nonessential in cell
culture systems, our data provide a plausible explanation as to
why MBV-selected mutations occur within the UL27 gene during
viral replication in vitro.
In addition to Tip60, pUL27 interacts with several components
of the proteasome, including the ubiquitin-independent protea-
some activator protein PSME3. The ubiquitin-proteasome
system does participate in efficient HCMV replication (Tran112 Cell Host & Microbe 9, 103–114, February 17, 2011 ª2011 Elsevet al., 2010). PSME3 directly regulates the steady-state protein
levels of p21Waf1/Cip1 (Chen et al., 2007; Li et al., 2007). We
observed an increase of p21Waf1/Cip1 protein level and cell-
doubling time upon disruption of PSME3 expression. Under
these conditions, we demonstrated an increase in the effective-
ness of MBV to inhibit wild-type HCMV replication. Our studies
suggest that coadministration of MBV with a pharmaceutical
drug that inhibits the proteasome, for example, bortezomib,
which induces p21Waf1/Cip1 expression (Yin et al., 2005), might
increase the efficacy of a viral kinase inhibitor.
Tip60 is essential for regulating stress responses and is a key
target of several viral proteins during infection. This includes HIV
Tat (Col et al., 2005; Creaven et al., 1999; Kamine et al., 1996;
Yamamoto and Horikoshi, 1997), human papillomavirus (HPV)
E6 (Jha et al., 2010), and human T cell lymphotropic virus type
1 p30II (Awasthi et al., 2005). Tat and E6 expression induce
Tip60 degradation, resulting in changes in gene expression.
We have demonstrated that expression of Tat within cells, or
the addition of Tat to the culture medium, restored the antiviral
activity of MBV against a pUL27-deficient virus. Further studies
will be required to determine whether Tat can increase the effi-
cacy of MBV in inhibiting wild-type HCMV replication. If this is
the case, then MBV may be an effective treatment for HCMV
infections in HIV-infected individuals, since soluble HIV Tat
complements the essential pUL27 activity. Our studies demon-
strated that complementation does not require coinfection of
a cell by both HCMV and HIV. By using a focused proteomics
approach, we have defined the mechanism of action for HCMV
pUL27 and identified potential ways to improve themanagement
of HCMV infections by altering the cellular environment.EXPERIMENTAL PROCEDURES
Biological Reagents
Primary human foreskin fibroblasts, U2OS, 293T, and Phoenix cells were prop-
agated in Dulbecco’s modified Eagle’s medium supplemented with 7% fetal
bovine serum (Invitrogen. Carlsbad, CA) and penicillin-streptomycin. Fibro-
blasts were obtained from newborn foreskins and grown until contact-
inhibited for 2 days for all experiments. Under these conditions, 97% of
the population was in G0/G1, based on DNA content. Quantifying living cells
were completed using ViaCount and Guava EasyCyte Mini Flow cytometer
(Millipore, Billerica, MA). pUL27-expressing cells were developed by transfect-
ing Phoenix cells (Kinsella and Nolan, 1996), using FuGENE 6 reagent (Roche,
Indianapolis, IN) with either pLXSN (Clontech, Mountain View, CA) or pLXSN-
UL27myc plasmids. Resulting media was added to fibroblasts and Geneticin
(Invitrogen) was used to select for expressing cells. The description of
recombinant viruses appears in Supplemental Information. Other reagents
used were purified HIV Tat (Roy et al., 2008), MG132 (EMD4Biosciences,
San Diego, CA), nocodazole (Sigma, St. Louis), and MBV (Viropharma, Exton,
PA). pLXSN-UL27myc was constructed by PCR amplifying the UL27 gene,
using a primer containing the myc tag sequence and cloned into pLXSN.
pCGN-UL27 was constructed by PCR amplification of UL27 and insertion
into pCGN in frame with the HA sequence. Other plasmids were: pCGN-
pp71 (Kalejta et al., 2003), pCMVTat (Dong et al., 2009), and pCMV-7.1-
Tip60 (Kim et al., 2006). The antibodies were: mouse anti-p21 (Thermo Fisher,
Waltham, MA), mouse anti-FLAG (Sigma), mouse anti-HA (Sigma), rabbit anti-
Myc (Cell Signaling, Danvers, MA), anti-Tip60 (Kim et al., 2006), rabbit anti-
TRRAP (Cell Signaling), rabbit anti-p400 (Bethyl Laboratories, Montgomery,
TX), mouse anti-PSME3 (BD Biosciences Franklin Lakes, NJ), mouse anti-
a-tubulin (Sigma), mouse anti-GAPDH (Santa Cruz, Santa Cruz, CA), mouse
anti-p16 (BD Biosciences), mouse anti-pUL44 (Virusys, Taneytown, MD),
mouse anti-pp28 (Silva et al., 2003), mouse anti-pUL26 (Munger et al.,
2006), and mouse anti-pUL122.ier Inc.
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The data are representative of at least two independent experiments, and
values are given as the mean of replicate experiments ± standard error of
the mean (SEM). For all experiments using the Student’s t test, we have
determined that the variances were not different using an F-test prior to using
a t test. The p value is indicated by an asterisk in the figures.
Mass Spectrometry Analyses
Approximately 1.53 108 low-passage fibroblast cells were infected with either
ADgfp or ADinUL27F virus at a moi of 3 pfu/cell. At 24 hpi, cells were washed
and harvested as previously described (Moorman et al., 2008). A detailed
description is provided in Supplemental Information.
Analysis of Protein, DNA, and Gene Expression
Immunoprecipitation, western blot analysis, and immunofluorescence were
completed as previously described (Terhune et al., 2010). Immunofluores-
cencewas observed using a Nikon Eclipse TS100microscope (Nikon,Melville,
NY). Viral DNA content and RNA expression from infected cells were deter-
mined using quantitative real-time PCR as previously described (Terhune
et al., 2010) and sequence-specific primers (Mitchell et al., 2009). Quantities
for unknown samples were defined relative to an arbitrary standard curve con-
sisting of 10-fold serial dilutions of one sample and completed for each primer
pair. Primers for p21 were 50-GGCGTTTGGAGTGGTAGAAAT-30 and 50-TGGA
GACTCTCAGGGTCGAAA-30. RACE analysis for HCMV transcripts has been
previously described (Mitchell et al., 2009). Primers for Tip60 were 50-TGCCCT
TGCGGTAAATCTCATTGC-30 and 50-AACTCACCACATTGCCTGTCCTCT-30.
RNA Interference Analysis
Disruption of PSME3 and Tip60 protein expression in primary fibroblasts was
completed using shRNA as previously described (Terhune et al., 2010). The
control shRNA consisted of a scrambled sequence (Terhune et al., 2010),
while sequences for PSME3 and Tip60 were obtained from Mission RNAi
(Sigma) (Moffat et al., 2006). For PSME3, sequences were shPSME3-1
(Mission clone ID# TRCN0000058071), shPSME3-2 (TRCN0000058070),
and shPSME3-3 (TRCN0000058069). For Tip60, sequences were shTip60-2
(TRCN0000020317) and shTip60-3 (TRCN0000020318).
Cell-Cycle Analysis
Subconfluent U2OS cells were transfected with pCGN-pp71 or pCGN-UL27
vector using FuGENE 6 transfection reagent (Roche). At 24 hr posttransfection,
75 ng/ml of nocodazole was added to the culture media, and cells were
allowed to grow for 16 hr. After treatment, transfected cells were harvested
and fixed in 70% ethanol. Another sample was released from nocodazole
by washing in PBS and allowed to propagate in culture media for 12 hr
before harvest. Viral protein expression was determined by staining cells using
anti-HA antibody and a secondary antibody conjugated to Alexa Fluor 488
(Invitrogen). DNA content was determined by treating cells with Cell Cycle
Reagent (Millipore) and incubating them in the dark for 30 min. The cell-cycle
analysis was completed on a Guava EasyCyte Mini flow cytometer (Millipore).
Transfected cells were differentiated from untrx cells by gating for viral protein
expression. The flow cytometry data was analyzed using FlowJo Analysis
Software (Tree Star, Ashland, OR).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, one figure and one table and can be found with
this article at doi:10.1016/j.chom.2011.01.006.
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